您当前位置：首页 > 国际期刊-Current Hematologic Malignancy Reports期刊投稿发表详细信息

Current Hematologic Malignancy Reports Q2

期刊收录：
SCIE
Scopus

基本信息

期刊ISSN：
1558-8211
期刊简拼：
CURR HEMATOL MALIG R
年发文章数：
34
E-ISSN：
1558-822X
Gold OA文章占比
10.17%
研究文章占比：
0.00%
是否OA：
No
Jcr分区：
Q2
中科院分区：
3区

出版信息

出版商：
Springer US
涉及研究方向：
ONCOLOGY-HEMATOLOGY
出版国家：
UNITED STATES
出版语言：
English
出版周期：
6 issues per year
出版年份：
2006

2023-2024最新影响因子:2.7
自引率:3.70%
五年影响因子:3
JCI期刊引文指标:0.41
h-index:28
CiteScore:6.00

期刊关键词

2区 SCIE Scopus 医学 3区 HEMATOLOGY 血液学 ONCOLOGY 肿瘤学

期刊简介

his journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, ｓｅｌｅｃｔ topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

《Current Hematologic Malignancy Reports》期刊已被查看：次
期刊简写：CURR HEMATOL MALIG R

此期刊被最新的JCR期刊SCIE收录